Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Cirrhosis Portal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT04436601
What this trial is testing

Polyethylene Glycol Versus Lactulose on Hepatic Encephalopathy in Patients With Cirrhosis;(PEGHE Trial)

Who this might be right for
Hepatic Encephalopathy
Aga Khan University 102
Early research (Phase 1)Study completedNCT05013502
What this trial is testing

Empagliflozin in Diuretic Refractory Ascites

Who this might be right for
Liver CirrhosisCirrhosisAscites+2 more
Stanford University 14
Large-scale testing (Phase 3)UnknownNCT06470386
What this trial is testing

The Efficacy and Safety of Alverine in the Treatment of Portal Hypertension in Patients With Liver Cirrhosis

Who this might be right for
Hypertension, Portal
Shanghai Changzheng Hospital 178
Not applicableEnded earlyNCT03202498
What this trial is testing

Safety and Tolerability of Yaq-001 in Patients With Cirrhosis

Who this might be right for
Liver Cirrhosis
Yaqrit Ltd 31
Post-approval studies (Phase 4)UnknownNCT02398357
What this trial is testing

The Effect of Anticoagulation After Endoscopic Therapy in Cirrhotic Patients With Portal Vein Thrombosis

Who this might be right for
Portal Vein ThrombosisLiver Cirrhosis
Shanghai Zhongshan Hospital 96
Early research (Phase 1)Study completedNCT07394309
What this trial is testing

Study of Hydroxynidone Capsules in Patients With Hepatic Impairment and Matched Healthy Controls

Who this might be right for
Liver Fibrosis
Beijing Continent Pharmaceutical Co, Ltd. 30
Not applicableActive Not RecruitingNCT07437638
What this trial is testing

Clinical Efficacy and Survival Prediction Analysis of Transjugular Intrahepatic Portosystemic Shunt in Patients With Liver Cirrhosis

Who this might be right for
Liver CirrhosisHepatic EncephalopathyTIPS
The Second Affiliated Hospital of Chongqing Medical University 624
Large-scale testing (Phase 3)WithdrawnNCT02837939
What this trial is testing

Transfer Factor Efficacy in the Management of Cirrhosis-associated Immune Dysfunction

Who this might be right for
CirrhosisLiver Failure
Martin Janičko
Not applicableUnknownNCT02692430
What this trial is testing

The International Imaging Registry in Liver Cirrhosis (BAVENO-VI SPSS GROUP).

Who this might be right for
Liver CirrhosisPortal HypertensionHepatic Encephalopathy
Hospital Universitari Vall d'Hebron Research Institute 1,000
Not applicableUnknownNCT06358092
What this trial is testing

Two-dimensional Shear Wave Elastography for Assessment of Cirrhosis and Portal Hypertension

Who this might be right for
Cirrhosis, LiverPortal Hypertension
Third Affiliated Hospital, Sun Yat-Sen University 112
Testing effectiveness (Phase 2)Study completedNCT02462967
What this trial is testing

Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis

Who this might be right for
Hypertension, Portal
Galectin Therapeutics Inc. 162
Not applicableStudy completedNCT01447667
What this trial is testing

Magnetic Resonance Elastography (MRE) as a Predictor of HCC Recurrence After Radiofrequency Ablation (RFA)

Who this might be right for
Hepatic FibrosisHepatocellular Carcinoma
Seoul National University Hospital 72
Post-approval studies (Phase 4)Study completedNCT02023229
What this trial is testing

Branched Chain Aminoacid Supplementation in Patients With Liver Cirrhosis

Who this might be right for
Liver Cirrhosis
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 68
Large-scale testing (Phase 3)UnknownNCT05128305
What this trial is testing

Integrated Traditional Chinese and Clinical Medicine for Chronic Hepatitis B and Its Complication

Who this might be right for
Hepatic EncephalopathyCirrhosis, LiverPortosystemic Shunt
Qianfoshan Hospital 276
Early research (Phase 1)UnknownNCT02652351
What this trial is testing

Human Umbilical Cord-Mesenchymal Stem Cells for Hepatic Cirrhosis

Who this might be right for
Hepatic Cirrhosis
Shenzhen Hornetcorn Bio-technology Company, LTD 20
Early research (Phase 1)Study completedNCT01289951
What this trial is testing

Pharmacokinetic Study of Raltegravir in Human Immunodeficiency Virus/Hepatitis C Virus (HIV/VHC) Coinfected Patients With Advanced (Child-Pugh C) Hepatic Cirrhosis

Who this might be right for
Human Immunodeficiency VirusHepatitis C
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 10
Not applicableUnknownNCT05220956
What this trial is testing

Impact of Time-restricted Feeding in NAFLD

Who this might be right for
Fatty Liver DiseaseFatty LiverFatty Liver, Nonalcoholic
Johannes Gutenberg University Mainz 100
Testing effectiveness (Phase 2)Study completedNCT02230670
What this trial is testing

IDN-6556 in Subjects With Liver Cirrhosis

Who this might be right for
Liver CirrhosisHepatic Cirrhosis
Conatus Pharmaceuticals Inc. 87
Not applicableStudy completedNCT04959110
What this trial is testing

Citrate Pharmacokinetics in Critically Ill Liver Failure Patients Receiving CRRT

Who this might be right for
Citrate ToxicityRegional Citrate AnticoagulationLiver Failure, Acute+3 more
Chulalongkorn University 20
Early research (Phase 1)Study completedNCT00896597
What this trial is testing

Reproducibility of Child-Turcotte-Pugh (CTP) Rating and NRL972 Pharmacokinetics in Patients With Cirrhosis

Who this might be right for
Hepatic Cirrhosis
Norgine 240
Next Page